It isn’t the biotechnology or even its efficacy.
Somehow, shrouded in secrecy and a total lack of disclosure, lies a roll-out and marketing problem. Most on this board believe Hayward is incompetent in conveying to the range of potential users of this technology, the practical applications.
I.E: good salesmen and marketers sell products and develop verticals.
Lab scientists don’t do this.
This product will not and hasn’t sold itself. The proof is in black and white, Quarter after endless Quarter.